Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment.

Davidson D, Wirtz PW, Gulliver SB, Longabaugh R.

Psychopharmacology (Berl). 2007 Sep;194(1):1-10. Epub 2007 May 19.

PMID:
17514344
2.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
3.

Does family history of alcoholism moderate naltrexone's effects on alcohol use?

Capone C, Kahler CW, Swift RM, O'Malley SS.

J Stud Alcohol Drugs. 2011 Jan;72(1):135-40.

PMID:
21138720
4.

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.

Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.

Alcohol Clin Exp Res. 2007 Jul;31(7):1179-87. Epub 2007 Apr 19.

PMID:
17451401
5.

What role does measuring medication compliance play in evaluating the efficacy of naltrexone?

Baros AM, Latham PK, Moak DH, Voronin K, Anton RF.

Alcohol Clin Exp Res. 2007 Apr;31(4):596-603.

PMID:
17374038
6.

Gabapentin combined with naltrexone for the treatment of alcohol dependence.

Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK.

Am J Psychiatry. 2011 Jul;168(7):709-17. doi: 10.1176/appi.ajp.2011.10101436. Epub 2011 Mar 31.

7.

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.

Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.

Alcohol Clin Exp Res. 2011 Oct;35(10):1804-11. doi: 10.1111/j.1530-0277.2011.01524.x. Epub 2011 May 16.

PMID:
21575016
8.

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.

Tidey JW, Monti PM, Rohsenow DJ, Gwaltney CJ, Miranda R Jr, McGeary JE, MacKillop J, Swift RM, Abrams DB, Shiffman S, Paty JA.

Alcohol Clin Exp Res. 2008 Jan;32(1):58-66. Epub 2007 Nov 20.

9.

Predictors of compliance with naltrexone among alcoholics.

Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, Gordon A, Eaton CA.

Alcohol Clin Exp Res. 2000 Oct;24(10):1542-9.

PMID:
11045863
10.

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.

Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93.

PMID:
11093966
11.

Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?

Baros AM, Latham PK, Anton RF.

Alcohol Clin Exp Res. 2008 May;32(5):771-6. doi: 10.1111/j.1530-0277.2008.00633.x. Epub 2008 Mar 11.

12.

Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.

Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis M.

JAMA Psychiatry. 2015 May;72(5):430-7. doi: 10.1001/jamapsychiatry.2014.3053.

PMID:
25760804
13.

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting.

Latt NC, Jurd S, Houseman J, Wutzke SE.

Med J Aust. 2002 Jun 3;176(11):530-4.

PMID:
12064984
14.

Adverse effects of oral naltrexone: analysis of data from two clinical trials.

Oncken C, Van Kirk J, Kranzler HR.

Psychopharmacology (Berl). 2001 Apr;154(4):397-402.

PMID:
11349393
15.

Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.

King A, Cao D, Vanier C, Wilcox T.

Alcohol Clin Exp Res. 2009 Jun;33(6):1044-50. doi: 10.1111/j.1530-0277.2009.00925.x. Epub 2009 Mar 19.

16.

Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.

Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK.

Alcohol Clin Exp Res. 2001 Nov;25(11):1634-47.

PMID:
11707638
17.

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study.

Gastpar M, Bonnet U, Böning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R.

J Clin Psychopharmacol. 2002 Dec;22(6):592-8.

PMID:
12454559
18.

A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.

Guardia J, Roncero C, Galan J, Gonzalvo B, Burguete T, Casas M.

Addict Behav. 2011 Mar;36(3):265-9. doi: 10.1016/j.addbeh.2010.11.006. Epub 2010 Nov 10.

PMID:
21146937
19.

Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.

O'Malley SS, Corbin WR, Leeman RF, DeMartini KS, Fucito LM, Ikomi J, Romano DM, Wu R, Toll BA, Sher KJ, Gueorguieva R, Kranzler HR.

J Clin Psychiatry. 2015 Feb;76(2):e207-13. doi: 10.4088/JCP.13m08934.

20.

Effectiveness of naltrexone in a community treatment program.

Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF.

Alcohol Clin Exp Res. 2004 Nov;28(11):1710-7.

PMID:
15547458

Supplemental Content

Support Center